propranolol has been researched along with colchicine in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (32.65) | 18.7374 |
| 1990's | 4 (8.16) | 18.2507 |
| 2000's | 10 (20.41) | 29.6817 |
| 2010's | 18 (36.73) | 24.3611 |
| 2020's | 1 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bai, R; Bolognesi, A; Brancale, A; Coluccia, A; Dondio, G; Ferlini, C; Gatti, V; Granata, I; Hamel, E; Iannitto, ML; La Regina, G; Lavecchia, A; Lavia, P; Maresca, B; Mariani, M; Mercurio, C; Novellino, E; Piscitelli, F; Porta, A; Rensen, W; Santoni, A; Silvestri, R; Soriani, A; Varasi, M | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bai, R; Brancale, A; Chen, F; Coluccia, A; Costa, B; Da Pozzo, E; Di Cesare, E; Dondio, G; Famiglini, V; Granata, I; Hamel, E; Iannitto, ML; La Regina, G; Lavia, P; Li, J; Maresca, B; Martini, C; Mercurio, C; Miranda Cona, M; Nalli, M; Ni, Y; Novellino, E; Pelliccia, S; Piscitelli, F; Porta, A; Reggio, A; Rensen, WM; Santoni, A; Silvestri, R; Soriani, A; Varasi, M; Vultaggio, S | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Guan, F; Guo, W; Hamel, E; Lee, KH; Li, L; Morris-Natschke, SL; Ohkoshi, E; Qian, K; Wang, L; Wang, LT; Wang, SB; Wang, XF; Xie, L; Yang, D; Yuan, S; Zhu, DQ | 1 |
| Alfonsi, R; Bai, R; Bigogno, C; Brancale, A; Caraglia, M; Coluccia, A; Da Pozzo, E; Di Marcotullio, L; Dondio, G; Famiglini, V; Gulino, A; Hamel, E; La Regina, G; Lavia, P; Marinelli, L; Martini, C; Mazzoccoli, C; Mercurio, C; Miele, A; Monti, L; Nalli, M; Novellino, E; Passacantilli, S; Pelliccia, S; Porto, S; Ricci, B; Ruggieri, V; Santoni, A; Silvestri, R; Soriani, A; Varasi, M; Verrico, A; Vultaggio, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alam, MA; Drewes, LR; Gurrapu, S; Jonnalagadda, SK; Lueth, EA; Mereddy, VR; Nelson, GL; Ronayne, CT; Solano, LN | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Abouf, M; Abutaleb, NS; Chen, L; Elsebaei, MM; Ghiaty, A; Hegazy, YA; Malwal, SR; Mayhoub, AS; Mohammad, H; Oldfield, E; Seleem, MN; Zhang, J | 1 |
| Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
| Balter, NJ; Cowden, MW; Schwartz, SL | 1 |
| Blackard, WG; Kikuchi, M; Rabinovitch, A; Renold, AE | 1 |
| Dartsch, PC; Hombach, V; Kochs, M; Osterhues, H; Roth, D; Seitzer, U; Voisard, R | 1 |
| Haas, N; Preston, E; Triandafillou, J | 1 |
| Morenz, E; Morenz, J; Schmidt, D | 1 |
| Hoffstein, S; Kammerman, S; Tai, HH; Weissmann, G; Zurier, RB | 1 |
| Hawkins, D | 1 |
| Gale, RP; Zighelboim, J | 1 |
| Fleckenstein, L; Lasagna, L; Mazzullo, JM; Mundy, GR; Sundaresan, PR; Weintraub, M | 1 |
| Gray, ME; LeQuire, VS; Mettler, NR; Schuffman, S | 1 |
| Dulis, BH; Wilson, IB | 1 |
| Hülsmann, WC; Stam, H | 1 |
| Klein, I | 1 |
| Bernard, B; Docter, R; Hennemann, G; Krenning, EP; Visser, T | 1 |
| Feller, DJ; Fontaine, RN; Schroeder, F; Weston, KG | 1 |
| Mornex, R; Rousset, B | 1 |
| Borda, LJ; Henry, PD; Shuchleib, R | 1 |
| Nicolas, P; Perret, GY; Vassy, R; Yin, YL | 1 |
| Abdelmalek, A; Ayad, G; Thornton, SN | 1 |
| Landwojtowicz, E; Seelig, A | 1 |
| Attwood, D; D'Emanuele, A; Jevprasesphant, R; Penny, J | 1 |
1 review(s) available for propranolol and colchicine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
48 other study(ies) available for propranolol and colchicine
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Caspase 3; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Furans; Humans; In Vitro Techniques; Indoles; Injections, Intravenous; Male; Mice; Mice, Nude; Microsomes, Liver; Pyrroles; Solubility; Structure-Activity Relationship; Thiophenes; Tubulin Modulators | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indoles; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice; Microsomes, Liver; Mitosis; Permeability; Polymerization; Pyridines; Reactive Oxygen Species; Rhabdomyosarcoma; Solubility; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Optimization of 4-(N-cycloamino)phenylquinazolines as a novel class of tubulin-polymerization inhibitors targeting the colchicine site.
Topics: Animals; Cell Proliferation; Colchicine; Female; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Models, Molecular; Quinazolines; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Tubulin Modulators | 2014 |
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer.
Topics: Animals; Cell Division; Cell Line, Tumor; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Hedgehog Proteins; Humans; Indoles; Killer Cells, Natural; Mice; Mitosis; Neoplasms; NIH 3T3 Cells; Tubulin | 2015 |
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Monocarboxylic Acid Transporters; Structure-Activity Relationship; Symporters | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mice; Microsomes, Liver; Staphylococcal Infections; Thiazoles | 2018 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Induction of membrane alterations by norepinephrine: studies with macrophages and phospholipids monolayers.
Topics: Animals; Cell Membrane; Colchicine; Cytochalasin B; Dose-Response Relationship, Drug; Female; Macrophages; Mice; Norepinephrine; Phospholipids; Propranolol; Vacuoles | 1977 |
An effect of hyposmolarity on insulin release in vitro.
Topics: Amiloride; Amylases; Animals; Atropine; Calcium; Choline; Colchicine; Diazoxide; Epinephrine; Glucagon; Glucose; Hypotonic Solutions; Imidazoles; In Vitro Techniques; Insulin; Insulin Secretion; Male; Osmolar Concentration; Ouabain; Pancreas; Phentolamine; Phenytoin; Propranolol; Rats; Sorbitol; Tolbutamide; Trypsin Inhibitors; Vinblastine | 1975 |
[The effect of propranolol, lisinopril, prednisolone, colchicine, etoposide and vincristine on proliferation of re-stenosing human plaque cells in vitro: cell culture as a prescreening system for prevention of restenosis].
Topics: Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Atherectomy; Cell Division; Cells, Cultured; Colchicine; Dipeptides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Etoposide; Humans; Lisinopril; Muscle, Smooth, Vascular; Prednisolone; Propranolol; Recurrence; Vincristine | 1992 |
Colchicine lesions of ventromedial hypothalamus: effects on regulatory thermogenesis in the rat.
Topics: Animals; Body Temperature Regulation; Colchicine; Cold Temperature; Eating; Male; Microinjections; Propranolol; Rats; Rats, Inbred Strains; Ventromedial Hypothalamic Nucleus | 1989 |
[Effect of drugs on superoxide formation by neutrophilic granulocytes].
Topics: Amphotericin B; Chloramphenicol; Colchicine; Fluphenazine; Humans; Hydrocortisone; Levamisole; Lithium; Lithium Carbonate; Neutrophils; Ouabain; Propranolol; Superoxides | 1987 |
Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.
Topics: Atropine; Carbachol; Cholera; Colchicine; Cyclic AMP; Cyclic GMP; Cytochalasin B; Deuterium; Enterotoxins; Glucuronidase; Histamine; Humans; Isoproterenol; Leukocytes; Lysosomes; Phagocytosis; Phenylephrine; Propranolol; Prostaglandins; Zymosan | 1974 |
Neutrophilic leukocytes in immunologic reactions in vitro. 3. Pharmacologic modulation of lysosomal constituent release.
Topics: Animals; Bucladesine; Chloroquine; Colchicine; Collagen; Epinephrine; Ethylmaleimide; Exocytosis; Ferritins; Glucose; Hydrocortisone; Iodoacetates; Isoproterenol; Latex; Lysosomes; Membranes; Microspheres; Models, Biological; Neutrophils; Phagocytosis; Phenylephrine; Propranolol; Rabbits; Salicylates; Theophylline; Vinblastine | 1974 |
Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity.
Topics: Acetylcholine; Aminophylline; Animals; Antibodies; Carbachol; Cholera; Colchicine; Cyclic AMP; Cyclic GMP; Cytotoxicity Tests, Immunologic; Edetic Acid; Epinephrine; Humans; Imidazoles; Immune Adherence Reaction; Immune Sera; Isoproterenol; Leukemia, Experimental; Neutrophils; Propranolol; Rabbits; Toxins, Biological | 1974 |
Current medical practice and the Food and Drug Administration. Some evidence for the existing gap.
Topics: Adult; Aged; Allopurinol; Angina Pectoris; Cephalexin; Child; Colchicine; Diuretics; Drug Labeling; Drug Prescriptions; Drug Therapy; Gout; Humans; Hypertension; Iron; Middle Aged; Physicians; Postoperative Complications; Propranolol; Retrospective Studies; United States; United States Food and Drug Administration; Uric Acid | 1974 |
beta-Adrenergic induced synthesis and secretion of phosphatidylcholine by isolated pulmonary alveolar type II cells.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cell Separation; Cells, Cultured; Colchicine; Cyclic AMP; Dose-Response Relationship, Drug; Male; Phosphatidylcholines; Propranolol; Pulmonary Alveoli; Rats; Terbutaline; Time Factors | 1981 |
The beta-adrenergic receptor of live human polymorphonuclear leukocytes.
Topics: Binding, Competitive; Colchicine; Cyclic AMP; Dihydroalprenolol; Humans; Isoproterenol; Kinetics; Lysosomes; Neutrophils; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1980 |
Effects of hormones, amino acids and specific inhibitors on rat heart heparin-releasable lipoprotein lipase and tissue neutral lipase activities during long-term perfusion.
Topics: Amino Acids; Animals; Colchicine; Cycloheximide; Cytosol; Glucagon; Heparin; Hormones; Hydrogen-Ion Concentration; Immune Sera; Insulin; Kinetics; Lipase; Lipoprotein Lipase; Male; Myocardium; Norepinephrine; Perfusion; Propranolol; Rats; Rats, Inbred Strains; Tunicamycin | 1984 |
Colchicine stimulates the rate of contraction of heart cells in culture.
Topics: Adenylyl Cyclases; Animals; Cells, Cultured; Colchicine; Dose-Response Relationship, Drug; Heart; Heart Rate; Humans; Infant, Newborn; Isoproterenol; Lumicolchicines; Myocardium; Propranolol; Rats; Stimulation, Chemical; Subcellular Fractions | 1983 |
Decreased transport of thyroxine (T4), 3,3',5-triiodothyronine (T3) and 3,3',5'-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs.
Topics: Adenosine Triphosphate; Amiodarone; Animals; Biological Transport, Active; Cells, Cultured; Colchicine; Cytochalasin B; Liver; Propranolol; Rats; Thyroxine; Triiodothyronine; Triiodothyronine, Reverse; Vinblastine | 1982 |
Drug-induced surface membrane phospholipid composition in murine fibroblasts.
Topics: Animals; Cell Membrane; Colchicine; Concanavalin A; Cytochalasin B; Ethanol; Fibroblasts; L Cells; Membrane Lipids; Mice; Pentobarbital; Phospholipids; Propranolol; Vinblastine | 1981 |
Identification of an intracellular pathway of thyroxine synthesis by dispersed thyroid cells.
Topics: Animals; Chlorpromazine; Colchicine; Fluorides; Iodine; Iodoproteins; Propranolol; Swine; Thyroid Gland; Thyroxine; Vinblastine | 1981 |
Hypoxic contraction of isolated canine coronary artery. Mediation by potassium-dependent exocytosis of norepinephrine.
Topics: Aerobiosis; Animals; Colchicine; Coronary Vessels; Dogs; Dopamine beta-Hydroxylase; Exocytosis; Female; Hypoxia; Male; Muscle Contraction; Norepinephrine; Potassium; Propranolol; Receptors, Adrenergic; Tyramine | 1980 |
Nongenomic effect of triiodothyronine on cell surface beta-adrenoceptors in cultured embryonic cardiac myocytes.
Topics: Animals; Cell Membrane; Cells, Cultured; Chick Embryo; Colchicine; Cycloheximide; Heart; Iodocyanopindolol; Microtubules; Myocardium; Pindolol; Propranolol; Protein Synthesis Inhibitors; Receptors, Adrenergic, beta; Time Factors; Triiodothyronine | 1997 |
Cardiovascular effects of catecholamines injected into the DBB of rats, influence of urethane anaesthesia and local colchicine.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthetics, Intravenous; Animals; Blood Pressure; Cardiovascular System; Catecholamines; Colchicine; Frontal Lobe; Heart Rate; Isoproterenol; Male; Microinjections; Propranolol; Rats; Rats, Wistar; Urethane | 1999 |
Structure-activity relationship of P-glycoprotein substrates and modifiers.
Topics: Adenosine Triphosphatases; Amiodarone; Amitriptyline; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; CHO Cells; Colchicine; Cricetinae; Cyclosporine; Daunorubicin; Diltiazem; Kinetics; Micelles; Progesterone; Propranolol; Structure-Activity Relationship; Verapamil; Vinblastine | 2000 |
The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability.
Topics: Acetates; Administration, Oral; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Cell Survival; Colchicine; Cyclosporine; Drug Carriers; Endocytosis; Epithelium; Humans; Laurates; Polyamines; Prodrugs; Propranolol; Solubility; Temperature | 2004 |